Darren WogmanNov 3, 202112 minQuality in clinical trial activitiesAchieving quality in clinical trial activities is a key target for both regulators and developers of medicines. Is this quest justified?
Darren WogmanJun 1, 202111 minWhat are the differences between embryonic stem cells and tissue stems cells? What are the differences between embryonic stem cells and tissue stems cells? Discuss the efficacy and safety. Darren Wogman MSc
Darren WogmanMay 25, 202110 minCritique of Hamdy FC et al. N Engl J Med 2016; 375:1415-1424Critique of Hamdy FC et al. 10-year outcomes after monitoring, surgery or radiotherapy for localised prostate cancer. N Engl J Med 2016; 375
Darren WogmanMay 25, 202110 minClinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability studyClinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability study on treating patients with schizophrenia
Darren WogmanMay 1, 202113 minUsing the target product profile write the following strategies and justify the strategy adoptedUsing the target product profile write the following strategies and justify the strategy adopted. Darren Wogman MSc
Darren WogmanMay 1, 202124 minA target product profile (TPP) for ATL-104. Use in Oral Mucositis (OM). Darren Wogman MScA target product profile (TPP) for ATL-104. Use in Oral Mucositis (OM). Darren Wogman MSc